http://www3.niaid.nih.gov/ NIAID News Releases en-us Sat, 07 Nov 2009 16:38:42 GMT http://www3.niaid.nih.gov:80/news/newsreleases/2008/proteomics.htm NIAID has awarded two five-year contracts to establish Clinical Proteomics Centers for Infectious Diseases and Biodefense. Mon, 09 Nov 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/ICACrenewal.htm The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has renewed the contract to continue studying asthma in children living in lower-income, inner-city environments. Wed, 04 Nov 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/ImmunologyAwards.htm NIAID has awarded approximately $208 million to two programs that support research to better understand the human immune response to emerging and re-emerging infectious diseases, including those that may be introduced into a community through acts of bioterrorism. Wed, 04 Nov 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/healthaffairs.htm In a new article in Health Affairs, Anthony S. Fauci, M.D. and Gregory K. Folkers, M.S., M.P.H., discuss the urgent imperative both to scale up proven tools of HIV treatment and prevention, and to develop bold new interventions—from curative therapies to vaccines and other new prevention modalities. Tue, 03 Nov 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/H1N1pregnantresults.htm Healthy pregnant women mount a robust immune response following just one dose of 2009 H1N1 influenza vaccine, according to initial results from an ongoing clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. Mon, 02 Nov 2009 15:19:42 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/interimpedsdata.htm NIAID today announced interim results that show that children nine years of age and younger have a significantly improved immune response when given a second 15-microgram dose of 2009 H1N1 influenza vaccine. Mon, 02 Nov 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/MalariaEradication.htm Although malaria has been controlled in many local and regional populations, the permanent elimination of malaria parasites throughout the world remains an elusive goal, and the disease continues to claim nearly one million lives each year. Fri, 30 Oct 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/strepvax.htm Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have completed a Phase II clinical study that indicates a vaccine to prevent Group B Streptococcus (GBS) infection is possible. Thu, 29 Oct 2009 19:22:43 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/fluDrift.htm Influenza viruses evade infection-fighting antibodies by constantly changing the shape of their major surface protein. Researchers from NIAID have proposed a new explanation for the evolutionary forces that drive antigenic drift. Thu, 29 Oct 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID) http://www3.niaid.nih.gov:80/news/newsreleases/2009/herpesvirus.htm Mon, 26 Oct 2009 00:00:00 GMT niaidnews@niaid.nih.gov (NIAID)